Given the limited efficacy of current anti-fibrotic therapies and the substantial morbidity associated with progressive pulmonary fibrosis, identification of novel pathways capable of modulating fibroblast activation and ECM remodelling remains a major therapeutic priority
While causation cannot be confirmed from this observational study, the findings provide important data for clinicians and patients with obesity and/or type 2 diabetes to consider as we continue to learn more about the possibilities of GLP-1RA therapies in breast cancer survivorship, she said
(, Hims & Hers)
A glutathione S-transferase with glutathione-peroxidase activity from Arabidopsis thaliana
Your First Consultation with Dr
Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al